Unicef, Baby Formula Makers Fight While Infants Die
Women in Africa, who have recently given birth, are being sent home from the hospital with a warning that breastfeeding could kill their children. Unfortunately, many of these women have no alternative.
They are forced to choose between watching their child starve to death, or later die of AIDS. With more than 15 million people in sub-Saharan African dead from the epidemic, the warnings are sincere but insufficient.
UNICEF, an arm of the United Nations, is fighting with baby formula companies to give women an alternative. An estimated 1.1 million infants have become infected with AIDS from their mother's milk. However a political battle keeps formula from reaching those in need. Major baby formula companies are willing to donate; UNICEF is not willing to receive.
In the 1970s, Nestle and other formula makers gave free samples to mothers in developing countries. However, the free samples quickly ran out and women began diluting the formula to feed their children. After their milk had dried up and the formula was gone, many children began dying of starvation. Most women simply could not afford to buy the formula.
Protesters worldwide held Nestle and other formula companies responsible for luring poor women into using their product with pictures of fat-formula fed babies. UNICEF refused cash donations from formula makers, as it has done with tobacco companies and the makers of land mines.
In the 1980s, the World Health Organization released a document specifically labeling how baby-formula companies could advertise and prohibited the distribution of free samples. However, this policy was established long before the AIDS epidemic hit Africa. UNAIDS officials said that UNICEF should put aside any problems with the companies out of a moral obligation to the millions suffering in Africa. Wyeth-Ayerst Laboratories Inc. and Nestle have both said they would be willing to donate significant amounts of formula if asked.
However, the companies are not willing to donate the formula without the consent of UNICEF. They fear bad publicity and further boycotts.
In the meantime, an estimated 90 out of every 1,000 women in sub-Saharan Africa are suffering from AIDS.
Source: The Wall Street Journal
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
